Pilot Study on the Feasibility of Using Smartphone Data as a Diagnostic Marker for Alzheimer's Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age60+
SponsorPoitiers University Hospital
About this trial
This study will compare smartphone usage data between three groups of patients diagnosed with either a memory complaint, mild cognitive decline, or Alzheimer's disease.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient consulting in routine care in one of the CMRR
No sensory impairment that may compromise smartphone use
Disqualifiers
Inability to perform MMSE or MMSE < 20 ;
Other neurodegenerative condition (Parkinson's disease, Lewy body disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis)
Severe anxiety or depressive disorder HADS score ≥ 17
Terminal phase of a severe disease
Trial design
Design model
Parallel
Treatments tested in this trial
Recording of smartphone usage data
Other interventionRecording of smartphone usage data
Treatment groups
90 Participants
are divided into 3 treatment groupsGroup A: Memory complaintOther 1 intervention
Group B: Mild cognitive declineOther 1 intervention
Group C: Alzheimer's DiseaseOther 1 intervention
Trial outcomes
Primary outcomes
1
Comparison of a mathematical combination
The comparison of a mathematical combination of the different parameters collected during the three months of smartphone data recording
Time frame
Up to three monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Poitiers University Hospital
Lead sponsor
University of Poitiers
Collaborator
Source ClinicalTrials.gov